Giorgio Raimondi retweeted
🎉Congratulations to Dr. Shenda Hou, our first grad student of @VCALabHopkins, who successfully defended her doctoral thesis! 👏👏
Excited to share our freshly published collaboration with the @JGreenGroup and @SpanglerLab groups on a new #immunoengineering approach to expand antigen specific #Treg and treat #autoimmunity. Thank you to all the teams for such a great effort!
science.org/doi/10.1126/scia…
.@HopkinsMedicine study (bit.ly/3oDsWU3) in @ScienceAdvances shows microparticles deliver therapy to ‘tip balance’ of #ImmuneCells from bad to good in mice with #MS like disease, reversing symptoms & often curing. @HopkinsPlastic @VCAlabHopkins @JGreenGroup @SpanglerLab
1
3
345
A very nice way to start the New Year!
We are having fun working with @JHUAPL group of Dr. Julia Patrone on using #LipidNanoparticles for oral antigen and drug delivery.
More to come...
(thank you @JDRF and @HopkinsMedicine for your support!)
lnkd.in/eMjNfhWN
1
267
Very excited to being collaborating with Jamie Spangler, together with many great scientists, in this work. Hats off to Derek and Marcos!
cell.com/cell-reports/fullte…
1
3
Happy to share our perspective on strategies to maximize the therapeutic potential of costimulation blockade in transplant rejection:
lnkd.in/eZ8WQDfQ
Great effort of Dr. Marcos Iglesias and beautiful collaboration with @clarsenEmory and Dr. Dan Brennan.
For those brave #transplant #immunologists who are not afraid of math 😅, here it is the product of an ongoing collaboration with Dr. Julia Arciero at @IUPUI. Our small contribution to make #Treg #celltherapies a success for #tolerance and #rejection:
frontierspartnerships.org/ar…
The effect of #Interferons is complex and contextual! Great new work from the @cravedilab in @ImmunityCP shows that #IFNβ can synergize with CTLA4-Ig in promoting #Transplant survival.
cell.com/immunity/fulltext/S…
1
This work complements previous understanding that the combination of #IFNβ and #IL6 undermines immunoregulation:
onlinelibrary.wiley.com/doi/…
So much to still understand about these differential effects. Go #JAKSTAT signaling pathways!
Giorgio Raimondi retweeted
The person who talks the most is the most likely to become the leader.
Data: regardless of intelligence and expertise, groups elevate those who command the most airtime.
It's time to stop rewarding people for dominating the discussion, and start valuing quality over quantity.
And I thought I was the only one wondering why so many scientists answer questions with: "that's a good/great question!"
I tell my student not to do it...
freakonomics.com/podcast/gre…
Shout out to our amazing collaborators @NCI, @Joel_Peptides. Beautiful work lead by @PoulamiMajumderPhD to develop a Surface Fill Hydrogel that delivers miRNA to treat mesothelioma. Published in Nature Nanotechnology!
nature.com/articles/s41565-0…
Feeling a little lost in your career?
How about building your own MAP! facultyfactory.org/podcast/#… #mentoring thank you @JHUFacDev !
Giorgio Raimondi retweeted
IMMUNOLOGY AND IMMUNOTHERAPY – POSTDOCTORAL POSITION with @VCAlabHopkins
Johns Hopkins University, Baltimore, USA
jobrxiv.org/job/johns-hopkin…
#ScienceJobs
Thank you @JHElisseeff for promoting our collaborative work. We are having fun working with experts in #BiomedicalEngineering and #ImmunoEngineering at #TTEC. So excited to find new talented people to make #ImmuneTolerance a reality!
Great postdoc opportunity in the VCA Lab @VCAlabHopkins - hopkinsmedicine.org/vca-lab
A fantastically collaborative lab, working on immunotherapy of transplant rejection and autoimmunity merging immunology, advanced drug delivery, and bioengineering. Don’t miss this opportunity!
1
Giorgio Raimondi retweeted
Great postdoc opportunity in the VCA Lab @VCAlabHopkins - hopkinsmedicine.org/vca-lab
A fantastically collaborative lab, working on immunotherapy of transplant rejection and autoimmunity merging immunology, advanced drug delivery, and bioengineering. Don’t miss this opportunity!
Giorgio Raimondi retweeted
It’s a feature, not a bug!!
Phage displayed peptides typically lack post translational modifications (PTMs).
Here, we present PTM PhIP-Seq and use it for unbiased analysis of anti-citrullinated protein antibodies (ACPA) in #rheumatoidarthritis.
biorxiv.org/content/10.1101/…
Great way to end the year! Our manuscript on potentiating costimulation blockade with JAK inhibitors for #transplant #tolerance has been accepted by @AJT ! Great work VCALab!!! We see real clinical potential for this strategy and will be testing it. onlinelibrary.wiley.com/doi/…


















